Search
for
Sort by
Research 421–450 of 1000+
- A Natural Product Molecule of Artocarpus Heterophyllus Reverses Inflammation Due to the Effect of Acute Exposure of Prostate Tissue to Testosterone Enanthate in Wistar Rats
- 411 THE POTENTIAL OF CIRCULATING ENDOTHELIAL CELLS AS PROGNOSTIC BIOMARKERS IN PROSTATE CANCER
- 410 NON-INVASIVE DIAGNOSIS OF PROSTATE CANCER FROM BODY FLUIDS USING A PANEL OF TUMOR SUPPRESSOR GENES
- Total prostate volume as risk factor for semen pathologies in ageing male
- IMPACT OF LOW DOSE FINASTERIDE FOR THE TREATMENT OF ANDROGENIC ALOPECIA ON SERUM PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN MEN PARTICIPATED IN POPULATION-BASED SCREENING FOR PROSTATE CANCER
- Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss?
- Faculty Opinions recommendation of Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.
- Genetic analysis of the role of androgen metabolism in the pathogenesis of prostate cancer
- Patients with a large prostate show a higher prevalence of androgenetic alopecia
- 5α‐Reductase Isozymes and Androgen Actions in the Prostate
- Association between prostate‐specific antigen and serum testosterone: A systematic review and meta‐analysis
- Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Effects of Finasteride (MK-906), a 5<i>α</i>-Reductase Inhibitor, on Circulating Androgens in Male Volunteers*
- A New Look at the 5?-Reductase Inhibitor Finasteride
- Mechanism-Based Inhibition of Human Steroid 5α-Reductase by Finasteride: Enzyme-Catalyzed Formation of NADP−Dihydrofinasteride, a Potent Bisubstrate Analog Inhibitor
- Structure of human type II 5 alpha-reductase gene.
- Persistent Sexual Side Effects of Finasteride: Could They Be Permanent?
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- 9 Role of 5α-reductase in health and disease
- Guideline for the primary care management of male lower urinary tract symptoms
- Clinical Pharmacokinetics and Pharmacodynamics of Finasteride
- Critical Analysis on Characterization, Systemic Effect, and Therapeutic Potential of Beta-Sitosterol: A Plant-Derived Orphan Phytosterol
- Comparison of Finasteride (Proscar®) and Serenoa repens (Permixon®) in the Inhibition of 5-Alpha Reductase in Healthy Male Volunteers
- Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
- Anti-androgenic activities of Ganoderma lucidum
- Combined Sabal and Urtica extract vs finasteride in BPH (Alken stage I–II)
- A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of Botanically Derived Inhibitors of 5-<i>α</i>-Reductase in the Treatment of Androgenetic Alopecia
- Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum
- A model for the turnover of dihydrotestosterone in the presence of the irreversible 5α-reductase inhibitors GI198745 and finasteride